{ "items": [ "\n\n
Dakin H. et al, (2011), Pharmacoeconomics, 29, 1075 - 1091
\n \n \n \n\n \n
\n \n \nDakin H. et al, (2011), Trials, 12
\n \n \n \n\n \n
\n \n \nDakin H. et al, (2011), Pharmacoeconomics
\n \n \n \n\n \n
\n \n \nDakin HA. et al, (2011), Stat Med, 30, 2511 - 2535
\n \n \n \n\n \n
\n \n \nDakin HA. et al, (2011), Statistics in Medicine, 30, 2511 - 2535
\n \n \n \n\n \n
\n \n \nBreeman S. et al, (2011), J Bone Joint Surg Am, 93, 1473 - 1481
\n \n \n \n\n \n
\n \n \nChoy E. et al, (2011), Seminars in Arthritis and Rheumatism, 41, 335 - 345.e6
\n \n \n \n\n \n
\n \n \nDakin H. et al, (2010), Value Health, 13, 922 - 933
\n \n \n \n\n \n
\n \n \nDakin H. et al, (2010), Value Health, 13, 934 - 945
\n \n \n \n\n \n
\n \n \nDevlin N. et al, (2010), VALUE IN HEALTH, 13, A246 - A246
\n \n \n \n\n \n
\n \n \nOrme M. et al, (2010), Curr Med Res Opin, 26, 511 - 528
\n \n \n \n\n \n
\n \n \nPetrou S. et al, (2010), Value in Health, 13, 543 - 551
\n \n \n \n\n \n
\n \n \nDakin H. et al, (2010), Quality of Life Research, 19, 65 - 80
\n \n \n \n\n \n
\n \n \nWilliamson I. et al, (2009), Health Technology Assessment, 13
\n \n \n \n\n \n
\n \n \nWilliamson I. et al, (2009), Health technology assessment (Winchester, England), 13, 1 - 144
\n \n \n \n\n \n
\n \n \nWilliamson I. et al, (2009), Health Technology Assessment, 13, 1 - +
\n \n \n \n\n \n
\n \n \nLiedgens H. et al, (2008), Clin Drug Investig, 28, 583 - 601
\n \n \n \n\n \n
\n \n \nDakin HA. et al, (2008), JOURNAL OF HEPATOLOGY, 48, S256 - S256
\n \n \n \n\n \n
\n \n \nHaughney J. et al, (2007), THORAX, 62, A47 - A47
\n \n \n \n\n \n
\n \n \nDakin HA. et al, (2007), Clin Ther, 29, 1491 - 1507
\n \n \n \n\n \n
\n \n \n